Antibody-based Induction

Antibody-Based Induction is a therapeutic strategy in kidney transplantation that employs monoclonal or polyclonal antibodies to selectively deplete or modulate T cells or interleukin-2 receptors, thereby preventing acute rejection during the early post-transplant period.

101

Publications

5.6K

Citations

698

Authors

272

Institutions

Publications per year

2017–2026

10

Authors

698

  1. SB
    Suphamai Bunnapradist

    University of California, Los Angeles, United States

    7 publications · 160 citations

    7

    h-index

  2. GW
    George W. Burke

    University of Miami, United States

    5 publications · 641 citations

    5

    h-index

  3. MD
    Mark D. Stegall

    Mayo Clinic, United States

    5 publications · 436 citations

    5

    h-index

  4. GC
    Gaetano Ciancio

    University of Miami, United States

    4 publications · 432 citations

    4

    h-index

  5. KJ
    Kristen J. Gillingham

    University of Minnesota, United States

    3 publications · 82 citations

    3

    h-index

1–5 of 698

Venues

  1. Transplantation

    22 publications · 1.7K citations

    18

    h-index

  2. Transplantation Proceedings

    14 publications · 238 citations

    11

    h-index

  3. American Journal of Transplantation

    10 publications · 866 citations

    10

    h-index

  4. Clinical Transplantation

    8 publications · 299 citations

    8

    h-index

  5. PubMed

    Repository · 4 publications · 65 citations

    4

    h-index

1–5